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aromatherapy and hand massage to reduce
disruptive behaviour in people with dementia
Chieh-Yu Fu1,2, Wendy Moyle1,2,3* and Marie Cooke1,2,3Abstract
Background: Aromatherapy and hand massage therapies have been reported to have some benefit for people
with dementia who display behavioural symptoms; however there are a number of limitations of reported studies.
The aim is to investigate the effect of aromatherapy (3% lavender oil spray) with and without hand massage on
disruptive behaviour in people with dementia living in long-term care.
Methods: In a single blinded randomised controlled trial 67 people with a diagnosis of dementia and a history of
disruptive behaviour, from three long-term care facilities were recruited and randomised using a random number
table into three groups: (1) Combination (aromatherapy and hand massage) (n = 22), (2) Aromatherapy (n = 23),
(3) Placebo control (water spray) (n = 22). The intervention was given twice daily for six weeks. Data on residents’
behaviour (CMAI) and cognition (MMSE) were collected before, during and after the intervention.
Results: Despite a downward trend in behaviours displayed not one of the interventions significantly reduced
disruptive behaviour.
Conclusions: Further large-scale placebo controlled studies are required where antipsychotic medication is
controlled and a comparison of the methods of application of aromatherapy are investigated.
Trial registration: ACTRN12612000917831
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Physical restraints and antipsychotics are frequently used
to manage disruptive behaviours displayed by people
with dementia living in long-term care [1,2]. Both forms
of restraint can increase the risk of falls, extrapyramidal
symptoms, cerebrovascular adverse events, and meta-
bolic syndrome [3]. Several complementary and alterna-
tive medicine (CAM) modalities have received attention
as being potentially useful in the management of disrup-
tive behaviours in people with dementia. Aromatherapy
and hand massage offer an alternative approach to the risk
of pharmacological intervention such as antipsychotics.
Aromatherapy can be absorbed through application
to the skin or through the respiratory system. There is* Correspondence: w.moyle@griffith.edu.au
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reproduction in any medium, provided the oran assumption that the aroma and the constituents in
the essential oil enter the bloodstream and combine to
result in a psychological and physiological response [4].
Aromatherapy used to reduce agitated behaviours in
people with dementia has predominately focused on es-
sential oils believed to have a calming and sedative ef-
fect. Such studies have commonly used either Melissa
officinalis (Lemon balm) or Lavender essential oil. It is
believed that Lavender oil exerts a direct action on tryp-
tophan, and helps the relaxation response [5].
A Cochrane systematic review of aromatherapy and
dementia [6] identified only one study [7] that revealed a
statistically significant effect of aromatherapy on behav-
ioural and psychological symptoms of dementia (BPSD).
In this study [7] 72 people with severe dementia, from eight
nursing homes were randomly assigned to an intervention
group (10% Melissa officinalis, or a placebo of sunflower
oil. Both essential oils were combined with lotion andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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treatment. Aromatherapy in this study was associated with
a significant reduction in aggressive behaviours, as assessed
by staff using the Cohen-Mansfield Agitation Inventory [8],
Neuropsychiatric Inventory [9] and Dementia Care Map-
ping [10], in 35% of participants treated with melissa oil
and in 11% of those receiving the placebo. The Cochrane
review [6] identified methodological confounding effects
that may have influenced the study results such as the par-
ticipants were taking a range of pharmaceutical treatments
that may have been altered during the trial and therefore
influenced BPSD scores. They recommended further large-
scale studies were required as one small trial was insuffi-
cient evidence for the efficacy of aromatherapy on BPSD.
Two further systematic reviews have also reviewed the
use of aromatherapy. One of these (4) focused on aroma-
therapy use in the treatment of BPSD and the other fo-
cused more generally on aromatherapy for health care and
as a result included BPSD [11]. Both systematic reviews
suggest there are limited studies that demonstrate the ef-
fectiveness of aromatherapy and the majority of studies to
date have been challenged by severe methodological limi-
tations. Fung and colleagues [4] however, identified four
studies, including the Ballard study (already described)
that indicate aromatherapy might be regarded as a poten-
tially effective treatment for BPSD (4). The three studies
are outlined below.
A significant reduction in agitated behaviour using lav-
ender oil was identified in a cross-over randomised trial
in Hong Kong [12]. Seventy Chinese older people with
moderate to severe dementia were recruited for a study
of the effects of six-weeks of lavender or sunflower inha-
lations, with a two-week washout. Total mean scores of
the Chinese version of the Cohen-Mansfield Agitation
Inventory (CCMAI) showed a positive reduction from
24.68 to 17.77 (p < .001); mean scores on the Chinese
version of the Neuropsychiatric Inventory (CNPI) also
positively reduced from 63.17 (SD = 17.81) to 58.77 (SD =
16.74). The main limitation to this study was that raters
were not blinded to the treatment offered.
Lavender oil also had a positive effect on BPSD in an-
other study. A placebo controlled trial with 15 participants
with severe dementia using 2% lavender oil aromatherapy
steam every second day for a total of 10 sessions resulted in
60% (n = 9) of participants showing improvement, 33%
(n = 5) showed no change and 7% (n = 1) showed a worsen-
ing of agitated behaviour when compared to the control
group [13]. This study was limited by the small sample size.
The largest aromatherapy study to date was a double-
blind parallel-group placebeo-controlled randomised trial
across 3 centres in the UK using melissa oil [14]. In this
study 114 participants were allocated to 1 of 3 groups: pla-
cebo medication and active aromatherapy; active medica-
tion and placebo aromatherapy or placebo of both. ThePittsburgh Agitation Scale [15] and Neuropsychiatric
Agitation Inventory [9] were completed at 4 weeks and 12
weeks follow-up. There was no evidence that melissa oil
aromatherapy was superior to placebo or donepezil, an
anticholinesterase, in reducing BPSD. There was a change
from baseline to week 12 in quality of life (QOL), with the
aromatherapy group experiencing the best outcome.
A number of small studies have also combined essen-
tial oils in the belief that this would improve outcomes.
However, only one study has reported a significant reduc-
tion in agitated behaviours using a combination of essential
oils including lavender, camomile, rosemary and marjoram
[16]. Essential oils were provided in a footbath, massage on
upper body and hands or on pillows. However, the findings
were based only on observations. This study was further
limited by the lack of blinding, small sample size and data
collection undertaken by care staff [16]. In addition the ap-
plication of aromatherapy by massage or touch, rather than
inhalations may also confuse the findings as there is a small
amount of evidence suggesting that massage and touch by
themselves may influence BPSD [17,18].
In summary although the findings of the studies are
limited they suggest that aromatherapy and massage may
help to reduce BPSD in people with dementia. This cur-
rent study, aimed to overcome the following limitations of
previous studies; a clear explanation of the protocol in-
cluding length of treatment and blinding of the raters, use
of trained raters and an adequately powered sample to in-
vestigate the effect of aromatherapy, the aromatherapy oil
sprayed rather than massaged to reduce the potential im-
pact of massage, and an intervention group using aroma-
therapy combined with hand massage to identify the
impact of the combined intervention on BPSD in people
with dementia in long-term care (LTC) facilities. We
conducted a single blinded randomised controlled trial to
assess the effect of aromatherapy (3% lavender oil spray)
with and without hand massage on disruptive behaviour in
people with dementia living in long-term care. Lavender
oil was chosen because it was shown to have the most
consistent effect on aggressive and nonaggressive behav-
iours [12,13].Method
Study design
A total of 67 older people were randomised to receive
six weeks of twice daily aromatherapy, or aromatherapy
and hand massage, or water spray (placebo control). Pri-
mary outcomes assessed before, during, and post interven-
tion were aggression and agitation. All recruitment and
intervention protocols took place between February and
December 2006. Ethical approval to conduct the study was
obtained from the University Human Research Ethics
Committee and the management of each aged care facility.
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Participants were recruited from three LTC facilities lo-
cated in Brisbane, Australia, owned and operated by the
one provider and with a combined total of 284 beds.
The facility environments, staffing models and philoso-
phies of care were similar across the three facilities. To
ensure the intervention was targeted to residents who it
was assumed would get the most benefit from the inter-
vention participants had to meet the following inclusion
criteria: 1. aged 60 or over to avoid recruitment of per-
sons with early onset dementia; 2. living in a participat-
ing nursing home for at least three months to avoid
potential effects from transition to the nursing home; 3.
cognitive functional impairment indicative of a dementia
condition; MMSE score of 24 out of 30 or less; and fea-
tures of Alzheimer’s disease according to American Psy-
chiatric Association DSM-IV-TR [19]; 4. a documented
history of a minimum of two weeks of agitation or aggres-
sion in total (consecutively or 14 single days), within the
past three months; 5. a documented history of physical
and/or chemical restraint for agitation and aggression, in-
cluding PRN (as required) medication; 6. consent for par-
ticipation from resident’s family or health-attorney; 7. no
known allergic reaction to lavender oil; and 8. no recent
skin tears, lacerations, bruises, or redness and swelling
that might interfere with hand massage. Exclusion criteria
were: 1. a diagnosis of schizophrenia or mental retardation
to avoid the complication of dual diagnoses impacting on
treatment effect; 2. expected to be transferred to another
residential facility within the next 3 months.
We invited the facility care managers to identify resi-
dents who appeared to meet the selection criteria from a
population of 284. They then sent information and in-
formed consent forms to next of kin of the 165 residents
identified. Randomisation assignments were given to par-
ticipants following baseline testing; these were generated
using a random number table and a person not involved
in the study randomised participants into three groups in
each residential care facility. Participant demographics
were obtained from the facility manager who copied infor-
mation required for the study from resident records.
Interventions
Aromatherapy spray was used because it is a simple and
convenient way to provide the aromatherapy treatment
and control treatment dose. It also allowed the potential
confounding effect of massage to be controlled for in this
current study, with aromatherapy intervention groups with
and without massage. In comparison, a vaporizer would be
difficult to quarantine and would result in staff recognizing
treatment groups. Given the likelihood that participants
might have compromised olfactory systems [20], it was de-
cided that a direct spray onto individuals’ upper chest
would be an effective delivery method.This is the first recorded study to apply an essential oil
spray to people with dementia, and therefore there was
no precedent in the literature to follow when determin-
ing the essential oil spray dosage or an effective treat-
ment period. Literature was consulted to help determine
a suitable dosage regimen and frequency of application
[7,21-23]. Aromatherapy guidelines were followed to re-
duce the risk of skin irritation, the guidelines recom-
mend a maximum concentration of 3% essential oil as a
safe dosage for skin use [23,24]. A 3% lavender mist,
consisting of 75 drops of pure 100% lavender oil was
mixed with 4 ml essential oil solubiliser and 125 cc puri-
fied water. All bottles of oil were stored out of direct
sunlight.
An allergic skin test was carried out before commen-
cing the intervention and was applied to participants’
inner arm. The aromatherapy intervention consisted of
three sprays of lavender mist applied to the participants’
chest within a 30cm distance, avoiding the face and eyes.
The control group received water mist sprayed in the
same way. The length of time for the hand massage
followed the protocol of Snyder et al. [22] which found a
postive effect of agitation on people with dementia who
had received five minutes of hand massage twice a day
for 10 days: each hand was massaged for 2.5 minutes.
The interventions were administered by one researcher
and six trained research assistants. All treatments were
given twice a day, at two time periods, 9 am to 11 am and
2 pm to 4 pm, seven days a week for six weeks. Partici-
pants received treatments in a quiet and private environ-
ment, such as the participant’s room in an attempt to keep
staff and family blind to the intervention type. If necessary,
curtains and folding screens were used to screen partici-
pants from the view of the nursing staff.
Outcome measures
All primary outcome measures were assessed by facility
staff blind to treatment assignment. A cognitive assess-
ment was undertaken at baseline and at the end of the six
week intervention, using the Mini Mental State Examin-
ation (MMSE) [25]. The MMSE is the most widely used
instrument to measure cognitive functioning and has been
shown to have an excellent test/retest reliability of .89, and
internal consistency of .83 [26]. The maximum score is 30
points. An MMSE score from 19 to 24 points indicates
mild cognitive function impairment, a score from 10 to 18
indicates moderate cognitive impairment; and a score less
than 10 indicates severe cognitive impairment [27].
Participants’ aggressive/non aggressive and agitated be-
haviours were measured using the Cohen-Mansfield Agi-
tation Inventory-Short Form [8]. The CMAI-SF was
administered five times in the study: 1. within the month
prior to the intervention; 2. at the end of the second
week of intervention; 3. at the end of the fourth week of
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the end of the sixth week; and 5. six weeks after the
completion of the intervention, in week 12.
The Cohen-Mansfield Agitation Inventory (CMAI-SF)
is an internationally validated instrument that measures
behavioural disturbance in people with dementia in the
previous two weeks. The items are scored on a five point
frequency scale, from 1 “Never”, to 5 “A few times an hour
or continuing for half an hour or more”. The CMAI-SF is
completed by caregivers and takes approximately 10 mi-
nutes to complete. In the current study, to accommodate
staff leave, a trained research assistant (rater) asked small
groups of staff who were regular carers of the individual
to rate the individual’s behaviour over the previous fort-
night. The group discussed the rating to ensure there was
consensus in the rating. At anyone rating session there
were always a minimum of two carers who had previously
rated the individual. Retrospective reviews of each partici-
pant’s functional needs were assessed from patient record
data. This data recorded assessment data, including type
and amount of assistance required for daily living.Statistical analysis and sample size
The sample size calculation for this study was based on
a previous study [7] that explored the effectiveness of
aromatherapy on agitated behaviour in older adults. This
study was chosen as the authors also used the CMAI as
the primary outcome measurement and at the time there
was no other comparative study that used lavender oil.
The Ballard study found that the change in CMAI scores
post-intervention were 23.1 (SD = 12.85) for the inter-
vention group, and 7.3 (SD = 17.1) for the control group,
with an effect size of f = 0.52737. Using this reported ef-
fect size, G*Power a priori calculations, a sample size of
45 (15 in each group) to obtain a power of 0.95, with an
α of .05, using a repeated measures ANOVA analysis
framework was needed. Primary outcomes were percent-
age change from baseline to 6 weeks. All primary analyses
were conducted according to the intention to treat (ITT)
approach, which is to include the data of all randomised
participants regardless of whether they finish the treatment
[28]. Participants’ missing single items of baseline data
were replaced by stochastic regression imputation (SRI).
SRI substitutes missing data with mean and random value.
Responses were coded and entered into the Statistical
Package for Social Sciences (SPSS) program, version 15.0.
Data were checked for completeness and inconsistencies
to avoid entry errors [29]. Given the abnormal distribution
of test scores and the ordinal properties of the scale items
and scores, a nonparametric Kruskal-Wallis H test (the
nonparametric equivalent of ANOVA) was used to iden-
tify statistically significant outcomes [29]. Descriptive sta-
tistics were used to analyse the demographic data.Results
A total of 165 potential participants were identified from
the three facilities. Permission to assess for eligibility was re-
ceived from 86. Of these 19 did not meet the inclusion cri-
teria. As a result 67 residents who met the selection criteria
were recruited from the three facilities: 29 from Facility 1;
16 from Facility 2; and 22 from Facility 3. The participants’
age, frailty, and diagnoses all created participation chal-
lenges. One male resident died in the first week of the
study, and as no data were collected he was excluded. Five
participants or their relatives withdrew consent for partici-
pation and data during the six weeks of the intervention
stage of the study. Withdrawal of consent was related to
family wanting reassurance their family member was in the
intervention rather than control group and the team being
unable to reassure the family. The data for these individ-
uals was also excluded [28]. A visual flowchart of partici-
pants’ progress through the randomised trial is presented in
Figure 1.
Table 1 summarises participant demographics. Partici-
pants ranged in age from 61 to 93, with a mean age of
84 (SD = 6.36). The majority ranged in age from 80 to 89
(n = 43, 70.5%), regardless of which facility they lived in.
Close to 50% (n = 28) lived in a high care nursing home
setting: 31% (n = 19) lived in special care units. Nearly
90% (n = 53) relied on nursing staff to assist them with
daily activities, such as feeding and hygiene. Most partici-
pants had at least one or two sensory deficits: some vision
impairment was a health problem for a large majority (n =
51, 83.6%); followed by hearing impairment (n = 25, 41%);
and chronic pain (n = 19, 31.1%). More than one-third (n =
25, 41%) walked with an assistive appliance, and 18 (29.5%)
participants were chair-fast (not mobile). Fifteen (51.7%) of
those who were chair-fast because of a physical condition
also had a severe cognitive impairment. An Optimal Scaling
(SPSS) representation of the demographic profile of the
participants of all three facilities did not reflect differences
between the clientele of the facilities.
Table 2 sets out the participants’ diagnoses and their
cognitive impairment. Almost half (n = 29) had been di-
agnosed with ‘dementia’, the next largest group were those
diagnosed with ‘Alzheimer’s disease’ (AD) (n = 16, 26.2%).
Eight participants did not have a definitive diagnosis. They
did, however, have a cognitive impairment and met the
DSM-IV-TR criteria for AD [19]. The largest proportion
(n = 29, 47.5%) of participants had MMSE scores which
placed them within the category of severe cognitive impair-
ment. Fourteen (23%) participants with severe cognitive
impairment scored 0 on the MMSE, indicating they had
not been able to respond to any of the MMSE questions.
Of these 14 participants, 6 (42.9%) were in the combi-
nation group (aromatherapy and hand massage), 3 (21.4%)
were in the aromatherapy group, and 5 (35.7%) were in the
control group.
Potential participants from 
three facilities (n= 165)
Enrolment
Received permission from participants or 
relatives and assessed for eligibility (n= 86) 
Did not meet inclusion criteria 
(n= 19)
Met inclusion criteria (n= 67) 
Allocation randomised  Reason for exclusion            
MMSE 24/30 n= 15
Schizophrenia n=2
Hospitalization n=2
Combination group Aromatherapy group         Control group
n= 22 (33%)         n= 23 (34%) n= 22 (33%)
Follow-up
Withdrew consent and participation (n=5) , or died in the six weeks of the  
intervention (n=1). Total = 6 (9%)
Analysis
Combination group Aromatherapy group Control group
Analysed n= 19 (28%) Analysed n= 22 (33%) Analysed n= 20 (30%) 
completed intervention completed intervention completed intervention
Figure 1 Flow chart of participants’ progress through randomised trial.
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displayed verbal agitation, such as constant requests for
attention or help (n = 43, 70.5%), and physical agitation
(n = 53, 86.9%), such as wandering. A significant propor-
tion of the participants displayed verbal aggression (n = 25,
41%), and 18 (29.5%) displayed physical aggression, such as
hitting, kicking, throwing objects and tearing up materials.
More than half (n = 31, 50.8%) were regularly given an anal-
gesic such as paracetamol or aspirin. A major proportion
(n = 50, 82%) of participants were subject to both physical
and chemical restraint. Over 54% (n = 11) of the 19 partici-
pants who lived in special care units (SCU) were on anti-
psychotic medication.The CMAI-SF showed a high reliability for the
five times it was used with a Cronbach’s alpha estimate
from .87 to .91 and the Guttman split-high reliability esti-
mates from .78 to .89. Participants’ aggressive behaviours
were measured at five points in time, using the CMAI-SF
(see Table 4). In all subscales, apart from ‘Inappropriate
dress or disrobing’ the mean scores across the five time
points reduced, although not significantly. The biggest
decrease in mean score occurred in the nonaggressive
subscale of ‘General restlessness, performing repetitious
mannerisms, tapping, strange movements’ where the base-
line mean score decreased from 3.07 (SD = 1.47) to 2.28
(SD = 1.53). The average mean scores of the data recorded









90 & older 7 (11.5%)
Living setting
Hostel 14 (23%)
Nursing home 28 (46%)
Special care unit 19 (31%)
Care level
High care 53 (86.9%)
Low care 8 (13.1%)
Sensory deficits







Walking stick 2 (3.3%)
Mobile Walker 20 (32.8%)
Chair-fast (not mobile) 18 (29.5)
Table 2 Participants’ diagnoses and cognitive impairment
n (%)
Diagnosis
Cognitive impairment 8 (13.1%)
Dementia 29 (47.5%)
Alzheimer’s disease 16 (26.2%)
Vascular dementia 3 (4.9%)
Multi-infarct dementia 2 (3.3%)
Other (e.g. Toxic dementia) 3 (4.9%)
Baseline-Mini-mental status (score)
Mild (19–24) 9 (14.8%)
Moderate (10–18) 23 (37.7%)
Severe (0–9) 29 (47.5%)
Table 3 Participants’ aggressive behaviours, restraints,
and regular antipsychotic medications
n (%)
Aggressive behaviours
(can chose more than 1)
Verbal agitation 43 (70.5%)
Physical agitation 53 (86.9%)
Verbal aggression 25 (41.0%)
Physical aggression 18 (29.5%)
Restraints
No restraint used 1 (1.6%)
Physical restraint 1 (1.6%)
Chemical restraint 9 (14.8%)
Both physical and chemical 50 (82.0%)
Regular antipsychotic medicine
(1 or more could be chosen)
Risperidone 9 (14.8%)
Haloperidol 5 ( 8.2%)
Other (e.g. Temazepam, Zolpidem) 14 (22.8%)
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was 1.96 (SD = .72) and the four CMAI-SF sub scales
were: physical nonaggressive 2.11 (SD = .95); aggressive 1.77
(SD = .68); verbal agitation 2.33 (SD = 1.09); and hiding and
hoarding things 1.75 (SD = .96).
A Kruskall-Wallis H test showed that both the aro-
matherapy and placebo treatment groups had reduced
aggressive behaviours at the end of week six of the inter-
vention (p < .05). There were no significant differences in
participants’ mean scores for the CMAI across all periods
(p < .05).
Adverse events
No adverse events were reported in the trial.
Discussion
The results of this study did not demonstrate that the
two CAM modalities, aromatherapy alone, and aroma-
therapy combined with hand massage had any statisti-
cally significant effect on reducing participants’ aggression
and/or agitation. This is contrary to the findings of the
two earlier lavender oil studies by Holmes et al. [13] and
Lin et al. [12] that found a reduction in agitation ac-
cording to the CMAI [8] and the Pittsburgh Agitation
Scale [9]. In the current study the CMAI ‘agitation’ sub-
scale had the highest scores. All sub-scales showed a slight
reduction in aggressive behaviours at the second, third
and fourth data collection point but none of these reduc-
tions in aggressive behaviours was statistically significant.
There is no clear explanation why the results are different
in this study but it is suggested that this could be related
Table 4 Data summary for five time points of the Cohen-Mansfield Agitation
CMAI subscales/ five time points Baseline Week 2 Week 4 Week 6 Post-test
(n = 61) M (SD) M (SD) M (SD) M (SD) M (SD)
Nonaggression
05. Pace, aimless wandering, trying to get to a different place 2.48 (1.66) 2.30 (1.50) 2.38 (1.54) 2.33 (1.51) 2.18 (1.58)
06. General restlessness, performing repetitious mannerisms,
tapping, strange movements
3.07 (1.47) 2.61 (1.48) 2.48 (1.50) 2.41 (1.45) 2.28 (1.53)
07. Inappropriate dress or disrobing 1.74 (1.05) 1.79 (1.14) 1.67 (0.96) 1.77 (1.06) 1.77 (1.16)
08. Handling things inappropriately 2.0 (1.33) 1.80 (1.03) 1.79 (1.14) 1.75 (1.22) 1.56 (0.98)
Aggression
01. Cursing or verbal aggression 2.61 (1.28) 2.36 (1.17) 2.20 (1.21) 2.13 (1.23) 2.20 (1.15)
02. Hitting, kicking, pushing, biting, scratching, aggressive spitting 1.84 (1.07) 1.77 (1.01) 1.57 (0.97) 1.62 (0.90) 1.72 (1.02)
03. Grabbing onto people, throwing things, tearing things
or destroying property
2.02 (1.23) 1.90 (1.12) 1.98 (1.27) 1.82 (1.04) 1.89 (1.07)
04. Other aggressive behaviours or self- abuse 1.69 (1.04) 1.59 (1.02) 1.59 (1.02) 1.54 (1.03) 1.43 (0.87)
14. Screaming 1.36 (0.93) 1.21 (0.76) 1.31 (0.74) 1.30 (0.72) 1.28 (0.64)
Agitation
09. Constant request for attention or help 2.38 (1.45) 2.20 (1.45) 2.21 (1.52) 1.98 (1.32) 2.0 (1.39)
10. Repetitive sentences, calls, questions or words 2.82 (1.53) 2.56 (1.46) 2.49 (1.50) 2.34 (1.34) 2.41 (1.42)
11. Complaining, negativism, refusal to follow directions 2.75 (1.36) 2.38 (1.23) 2.25 (1.35) 2.03 (1.14) 2.13 (1.38)
Hiding & hold things
13. Hiding things, hoarding things 2.08 (1.44) 1.74 (1.06) 1.59 (1.01) 1.67 (1.04) 1.69 (1.15)
Note: The scale ranged from 1 (Never) to 5 (A few times an hour or continuous for half an hour or more). Question 12 Strange noise, did not fit into any
sub-groups; therefore it was excluded from the study.
Fu et al. BMC Complementary and Alternative Medicine 2013, 13:165 Page 7 of 9
http://www.biomedcentral.com/1472-6882/13/165to the application of the aromatherapy oil. In this study
the aromatherapy oil was sprayed onto participants’ upper
chest, whereas in previous studies the aromatherapy was
massaged in or given as an inhalation. Further research is
needed to compare the different type of application of es-
sential oils. In addition this study did not control for anti-
psychotic use and their use could have had a cofounding
effect on CMAI scores. Furthermore, although this study
did not demonstrate significant results there were individ-
uals who obviously benefited from the intervention. This
study supports the need to tailor interventions to the needs
and wishes of individuals. Further research is required to
identify if aromatherapy and/or hand massage is more ef-
fective in individuals who had prior enjoyable experiences
of aromatherapy and/or massage.
The study has methodological strengths that aimed to
avoid the limitations of previous studies in the area. The
research design, three treatment groups, including a con-
trol group avoided a short period of washout and the lack
of a comparative [30,31]. In addition, the six-week inter-
vention provided an appropriate length of treatment for
determining a dose–response [32,33]. Using a clearly iden-
tified concentration of a single essential oil (3% lavender
angustifolia) addressed limitations in previous studies,
which often failed to report standardised dosage informa-
tion [33]. The collection of pre-intervention participantdata provided baseline information and allowed for com-
parison with each post-test data set.
Study limitations
This study has several limitations. First, the sample size
somewhat limits its generalisability. Secondly, partici-
pants’ level of olfactory functioning may have affected
aromatherapy effectiveness. There is evidence that people
with dementia often have olfactory dysfunction. In par-
ticular, those people with dementia with Lewy bodies
[20,34]. An olfactory function test was not undertaken be-
cause of participants’ various levels of cognitive impair-
ment and disruptive behaviour. Despite providing training
for staff in each facility in the use of the CMAI, staff con-
tinued to make subjective judgments when asked to rec-
ord participants’ behaviours. Nursing staff often stated
that they viewed aggressive behaviours as a routine aspect
of caring for people with dementia, something they had to
deal with every day. Although this had the potential to im-
pact on the CMAI recordings the researchers aimed to
limit reliability issues by the rater asking a small group of
carers for their ratings of participant’s behaviour. This pro-
vided the opportunity for carers to discuss together and
confirm their perceptions of individual behaviours. Fur-
thermore aromatherapy treatment was used as an adjunct
to current interventions, both pharmacological and non-
Fu et al. BMC Complementary and Alternative Medicine 2013, 13:165 Page 8 of 9
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ipants’ routine medications. Over 45% of the participants
(n = 28) were on regular antipsychotic medication and this
prescribed medication might have affected their behav-
iours [12,19]. Although the intervention was performed in
the private areas of the care facility staff or family may
have become aware of the nature of the treatment given
to participants if the lavender oil odor remained in the en-
vironment following the treatment. However, given that
staff and family on occasion referred incorrectly to the
treatment a participant was receiving this seemed unlikely.
Conclusions
This study did not identify significant improvements in
aggressive behaviours of people with dementia who re-
ceived aromatherapy or who received aromatherapy in
combination with hand massage. These findings are im-
portant for practitioners to consider when deciding upon
whether to introduce aromatherapy. Practitioners must
consider individual needs, including assessment of the
triggers behind behaviours of concern and evaluate the
effect of any interventions, including aromatherapy or
massage put into place to manage the behaviour. The
findings are also important for researchers to consider in
their design of any future studies and indicate that fur-
ther large sample studies are required.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CF conceived of the study and its design, coordinated the research and
trained RAs. WM and MC oversaw the study and assisted in providing
methodological advice. All authors contributed to the drafting of the
manuscript. All authors read and approved the final manuscript. No writing
assistance was utilized.
Acknowledgement
This study was supported by a grant from Queensland Nursing Council
Grant - 2005 (RAN: 0548). Authors acknowledge the contribution of statistical
expertise of Dr. Peter Grimbeek and Dr. Jesus Lopez.
Author details
1Centre for Health Practice Innovation, Brisbane, QLD 4111, Australia. 2Griffith
Health Institute, Brisbane, QLD 4111, Australia. 3School of Nursing and
Midwifery, Griffith University, 170 Kessels Road, Brisbane, QLD 4111, Australia.
Received: 21 August 2012 Accepted: 3 July 2013
Published: 10 July 2013
References
1. Moore K, Haralambous B: Barriers to reducing the use of restraints in
residential elder care facilities. J Adv Nurs 2007, 58:532–540.
2. Nakahira M, Moyle W, Creedy D, Hitomi H: Attitudes toward dementia-
related aggression among staff in Japanese aged care settings. J Clin
Nurs 2009, 18:807–816.
3. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of
atypical antipsychotics for dementia: Meta-analysis of randomized,
placebo-controlled trials. Am J Geriatr Psychiatry 2006, 14:191–210.
4. Fung JKKM, Tsang HWH, Chung RCK: A systematic review of the use of
aromatherapy in treatment of behavioral problems in dementia.
Geriatr Gerontolo Int 2012, 12:372–382.5. Zeilmann CA, Dole EJ, Skipper BJ, McCabe M, Low Dog T, Thyne RL: Use of
herbal medicine by elderly Hispanic and non-His-panic white patients.
Pharmacotherapy 2003, 23:526–532.
6. Holt FE, Birks TPH, Thorgrimsen LM, Spector AE, Wiles A, Orrell M: Aroma
therapy for dementia. Cochrane DS Syst Rev 2003, 3, CD003150.
7. Ballard CG, O’Brien JT, Reichelt K, Perry EK: Aromatherapy as a safe and
effective treatment for the management of agitation in severe
dementia: The results of a double-blind, placebo-controlled trial with
Melissa. J Clin Psychiatry 2002, 63:553–558.
8. Cohen-Mansfield J, Marx M, Rosenthal A: A description of agitation in a
nursing home. J Gerontol 1989, 44:M77–M84.
9. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA,
Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment
of psychopathology in dementia. Neurology 1994, 44:2308–2314.
10. Innes A, Surr C: Measuring the well-being of people with dementia living
in formal care settings: The use of Dementia Care Mapping. Aging Ment
Health 2001, 5:258–268.
11. Lee MS, Choi J, Posadzki P, Ernst E: Aromatherapy for health care: An
overview of systematic reviews. Maturitas 2012, 7:257–260.
12. Lin PWK, Chan WC, Ng BFL, Lam LCW: Efficacy of aromatherapy
(Lavandula angustifolia) as an intervention for agitated behaviours in
Chinese older persons with dementia: A cross-over randomized trial.
Int J Geriatr Psychiatry 2007, 22:405–410.
13. Holmes C, Hopkins V, Hensford C, MacLaughlin V, Wilkinson D, Rosenvinge H:
Lavender oil as a treatment for agitated behaviour in severe dementia: A
placebo controlled study. Int J Geriatr Psychiatry 2002, 17:305–308.
14. Burns A, Perry E, Holmes C, Framcis P, Morris J, Howes MJR, Chazot P,
Lees G, Ballard C: A double-blind placebo-controlled randomized trial of
Melissa officinalis oil and donepezil for the treatment of agitation in
Alzheimer’s disease. Dement Geriatr Cogn Disord 2011, 31:158–164.
15. Rosen J, Burgio L, Killar M, Cain M, Allison M, Fogleman M, Zubenko GS: The
Pittsburg Agitation Scale: a user friendly instrument for rating agitation
in dementia patients. American J Geriatric Psychiatry 1994, 2:52–59.
16. Burleigh S, Armstrong C: On the scent of a useful therapy. J Dementia Care
1997, 5:21–23.
17. Hansen NV, Jorgensen T, Ortenblad L: Massage and touch for dementia.
Cochrane Database Syst Rev 2006, 4, CD004989. doi:10.1002/14651858.
CD004989.pub2.
18. Moyle W, Murfield J, O’Dwyer S, van Wyk S: The effect of massage on
agitated behaviours in older people with dementia: A literature review.
J Clinic Nursing 2012, 22:601–610. doi:10.1111/j.1365-2702.2012.04234.x.
19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental
Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
20. Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA:
Distinct patterns of olfactory impairment in Alzheimer’s disease,
semantic dementia, frontotemporal dementia, and corticobasal
degeneration. Neuropsychologia 2007, 45:1823–1831.
21. Snyder M, Egan EC, Burns KR: Efficacy of hand massage in decreasing
agitation behaviors associated with care activities in persons with
dementia. Geriatr Nurs 1995, 16:60–63.
22. Snyder M, Egan EC, Burns KR: Interventions for decreasing agitation
behaviours in persons with dementia. J Gerontol Nurs 1995, 21:34–40.
23. Battaglia S: The Complete Guide to Aromatherapy. 2nd edition. Brisbane: The
International Centre of Holistic Aromatherapy; 2002.
24. Price S, Price L: Aromatherapy for Health Professionals. 2nd edition. London:
Churchill Livingstone; 1999.
25. Folstein M, Folstein S, McHugh P: Mini-Mental-State: a practical method
for grading the cognitive state of patients for the clinician. J Psychiatr Res
1975, 12:189–198.
26. Tombaugh TN, Mclntyre NJ: The Mini-Mental State Examination: a
comprehensive review. J Am Geriatr Soc 1992, 40:922–935.
27. Galea M, Woodward M: Mini-Mental State Examination (MMSE). Aust J
Physiother 2005, 51:198.
28. Lachin JM: Statistical considerations in the intent-to-treat principle.
Control Clin Trials 2000, 21:167–189.
29. Polit D, Beck CT: Nursing Research: Generating and Assessing Evidence for
Nursing Practice. 8th edition. Philadelphia: Lippincott Williams & Wilkins; 2008.
30. Kim EJ, Buschmann MT: The effect of expressive physical touch on
patients with dementia. Int J Nurs Stud 1999, 36:235–243.
31. Remington R: Calming music and hand massage with agitated elderly.
Nurs Res 2002, 51:317–323.
Fu et al. BMC Complementary and Alternative Medicine 2013, 13:165 Page 9 of 9
http://www.biomedcentral.com/1472-6882/13/16532. Smallwood J, Brown R, Coulter F, Irvine E, Copland C: Aromatherapy and
behaviour disturbances in dementia: a randomized controlled trial.
Int J Geriatr Psychiatry 2001, 16:1010–1013.
33. Beshara MC, Giddings D: Use of the plant essential oils in treating
agitation in a dementia unit: 10 case studies. Int J Aromatherapy 2002,
12:207–212.
34. Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ,
Katzman R: Anosmia is very common in the Lewy body variant of
Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2005, 76:1342–1374.
doi:10.1186/1472-6882-13-165
Cite this article as: Fu et al.: A randomised controlled trial of the use of
aromatherapy and hand massage to reduce disruptive behaviour in
people with dementia. BMC Complementary and Alternative Medicine
2013 13:165.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
